1 |
Zou Z, Luo X, Chen Z, Zhang YS, Wen C. Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside. Theranostics 2022;12:891-909. [PMID: 34976219 DOI: 10.7150/thno.62685] [Reference Citation Analysis]
|
2 |
Królicki L, Kunikowska J. Theranostics – present and future. Bio-Algorithms and Med-Systems 2022;17:213-20. [DOI: 10.1515/bams-2021-0169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
3 |
Holik HA, Ibrahim FM, Elaine AA, Putra BD, Achmad A, Kartamihardja AHS. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker. Molecules 2022;27:3062. [PMID: 35630536 DOI: 10.3390/molecules27103062] [Reference Citation Analysis]
|
4 |
Kleynhans J, Sathekge M, Ebenhan T. Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy. Materials (Basel) 2021;14:4784. [PMID: 34500873 DOI: 10.3390/ma14174784] [Reference Citation Analysis]
|
5 |
Prihatiningsih MC, Ariyanto T, Putra EGR, Susilo VY, Mahendra I, Prasetyo I. Radioiodination of Modified Porous Silica Nanoparticles as a Potential Candidate of Iodine-131 Drugs Vehicle. ACS Omega 2022;7:13494-506. [PMID: 35559138 DOI: 10.1021/acsomega.1c06492] [Reference Citation Analysis]
|
6 |
Parrilha GL, dos Santos RG, Beraldo H. Applications of radiocomplexes with thiosemicarbazones and bis(thiosemicarbazones) in diagnostic and therapeutic nuclear medicine. Coordination Chemistry Reviews 2022;458:214418. [DOI: 10.1016/j.ccr.2022.214418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|